Carcinogenesis, Vol. 20, No. 10, 1933-1938,
October 1999
© 1999 Oxford University Press
Molecular Epidemiology and Cancer Prevention |
Preferential induction of guanine deletion at 5'-GGGA-3' in rat mammary glands by 2-amino- 1-methyl-6-phenylimidazo[4,5-b]pyridine
Carcinogenesis Division, National Cancer Center Research Institute,1-1 Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045,
1 Low Dose Radiation Risk and Carcinogenesis Research Group, National Institute of Radiological Sciences, Anakawa 4-9-1, Inage-ku, Chiba 263-8555 and
2 First Department of Pathology, Nagoya City University Medical School, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is known to induce a characteristic mutation, G deletion at the 5'-GGGA-3' site, preferentially in the lacI transgene of the colonic mucosa of Big Blue® rats (BBR) and mice and specifically in the Apc gene of rat colon tumors. In this study, lacI mutations of the mammary glands in PhIP-treated rats were investigated. Six-week-old female (BBRxSprague–Dawley)F1 rats were administered 10 gavages of 65 mg/kg/day PhIP. Mammary ducts were collected from the macroscopically normal mammary tissue of PhIP-treated and untreated rats at 56–69 weeks of age by collagenase treatment. The mutant frequencies were 25 ± 2.1x10–6 in control rats and 323 ± 44x10–6 in the PhIP-treated rats. By sequencing 40 and 177 mutants in the control and PhIP-treated groups, respectively, 34 and 149 mutations were considered independent mutations. In the control group, G:C
A:T transitions at CpG sites dominated and no G:C deletions were detected. In the PhIP-treated group, G:CT:A transversions were most frequent (43%), followed by single base pair deletions of G:C (21%). A total of nine deletions were at 5'-GGGA-3' sites, accounting for 29% of the G:C deletions and 6% of the 149 total mutations. Clusters of more than three mutations at one nucleotide position were observed at 12 positions and two were G deletions at 5'-GGGA-3' sites. Comparison of the PhIP-induced mutations in the mammary glands with those previously reported in the colon revealed that G:CT:A transversions occurred at a significantly higher frequency in the mammary glands and that G:C deletions occurred at a significantly lower frequency. However, the signature mutation, G deletion at the 5'-GGGA-3' site, was commonly observed in both tissues.
Abbreviations: BBM, Big Blue® mouse; BBR, Big Blue® rat; DMEM, Dulbecco's modified Eagle's medium; F344, Fischer 344; MF, mutant frequency; PhIP, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine; SD, Sprague–Dawley; SSCP, single-strand conformation polymorphism.
3 To whom correspondence should be addressed Email: tushijim{at}ncc.go.jp
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Fukuda, T. Takamura-Enya, Y. Masuda, T. Nohmi, C. Seki, K. Kamiya, T. Sugimura, C. Masutani, F. Hanaoka, and H. Nakagama Translesional DNA Synthesis through a C8-Guanyl Adduct of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in Vitro: REV1 INSERTS dC OPPOSITE THE LESION, AND DNA POLYMERASE {kappa} POTENTIALLY CATALYZES EXTENSION REACTION FROM THE 3'-dC TERMINUS J. Biol. Chem., September 18, 2009; 284(38): 25585 - 25592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hoshi, K. Morimura, H. Wanibuchi, M. Wei, E. Okochi, T. Ushijima, K. Takaoka, and S. Fukushima No-Observed Effect Levels for Carcinogenicity and for in vivo Mutagenicity of a Genotoxic Carcinogen Toxicol. Sci., October 1, 2004; 81(2): 273 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Fujiwara, M. Ochiai, T. Ohta, M. Ohki, H. Aburatani, M. Nagao, T. Sugimura, and H. Nakagama Global gene expression analysis of rat colon cancers induced by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Carcinogenesis, August 1, 2004; 25(8): 1495 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Boyiri, J. Guttenplan, M. Khmelnitsky, W. Kosinska, J.-M. Lin, D. Desai, S. Amin, B. Pittman, and K. El-Bayoumy Mammary carcinogenesis and molecular analysis of in vivo cII gene mutations in the mammary tissue of female transgenic rats treated with the environmental pollutant 6-nitrochrysene Carcinogenesis, April 1, 2004; 25(4): 637 - 643. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Snyderwine, H.-S. Yoon, L. P. Knight-Jones, M. Tran, H. A.J. Schut, and M. Yu Mutagenesis and DNA adduct formation in the mouse mammary gland exposed to 2-hydroxyamino-1-methyl-6-phenylimidazo-[4,5-b]pyridine in whole organ culture Mutagenesis, January 1, 2003; 18(1): 7 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yu and E. G. Snyderwine H-ras oncogene mutations during development of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced rat mammary gland cancer Carcinogenesis, December 1, 2002; 23(12): 2123 - 2128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kuramoto, K. Morimura, S. Yamashita, E. Okochi, N. Watanabe, T. Ohta, M. Ohki, S. Fukushima, T. Sugimura, and T. Ushijima Etiology-specific Gene Expression Profiles in Rat Mammary Carcinomas Cancer Res., July 1, 2002; 62(13): 3592 - 3597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yu, M. L. Jones, M. Gong, R. Sinha, H. A.J. Schut, and E. G. Snyderwine Mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the mammary gland of Big Blue rats on high-and low-fat diets Carcinogenesis, May 1, 2002; 23(5): 877 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Watanabe, E. Okochi, M. Mochizuki, T. Sugimura, and T. Ushijima The Presence of Single Nucleotide Instability in Human Breast Cancer Cell Lines Cancer Res., November 1, 2001; 61(21): 7739 - 7742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Stuart, J. G. de Boer, R. Haesevoets, J. Holcroft, J. Kangas, K. Sojonky, E. Thorleifson, A. Thornton, D. F. Walsh, H. Yang, et al. Mutations induced by 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in cecum and proximal and distal colon of lacI transgenic rats Mutagenesis, September 1, 2001; 16(5): 431 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Andreassen, R. Vikse, I.-L. Steffensen, J. E. Paulsen, and J. Alexander Intestinal tumours induced by the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in multiple intestinal neoplasia mice have truncation mutations as well as loss of the wild-type Apc+ allele Mutagenesis, July 1, 2001; 16(4): 309 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Brown, B. E. Hingerty, E. A. Guenther, V. V. Krishnan, S. Broyde, K. W. Turteltaub, and M. Cosman Solution structure of the 2-amino-1- methyl-6-phenylimidazo[4,5-b]pyridine C8-deoxyguanosine adduct in duplex DNA PNAS, June 28, 2001; (2001) 151251898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Brown, E. A. Guenther, K. H. Dingley, M. Cosman, C. A. Harvey, S. J. Shields, and K. W. Turteltaub Synthesis and spectroscopic characterization of site-specific 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine oligodeoxyribonucleotide adducts Nucleic Acids Res., May 1, 2001; 29(9): 1951 - 1959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Watanabe, E. Okochi, Y. Hirayama, Y. Shimada, K. Yanagihara, M. C. Yoshida, S. Takahashi, M. Mochizuki, T. Sugimura, M. Nagao, et al. Single Nucleotide Instability without Microsatellite Instability in Rat Mammary Carcinomas Cancer Res., March 1, 2001; 61(6): 2632 - 2640. [Abstract] [Full Text]
|
|
|
|
|
|
T. Sugimura Nutrition and dietary carcinogens Carcinogenesis, March 1, 2000; 21(3): 387 - 395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Stuart, J. Holcroft, J. G. de Boer, and B. W. Glickman Prostate Mutations in Rats Induced by the Suspected Human Carcinogen 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Cancer Res., January 1, 2000; 60(2): 266 - 268. [Abstract] [Full Text]
|
|
|
|
|
|
K. Brown, B. E. Hingerty, E. A. Guenther, V. V. Krishnan, S. Broyde, K. W. Turteltaub, and M. Cosman Solution structure of the 2-amino-1- methyl-6-phenylimidazo[4,5-b]pyridine C8-deoxyguanosine adduct in duplex DNA PNAS, July 17, 2001; 98(15): 8507 - 8512. [Abstract] [Full Text] [PDF]
|
|